跳至主要内容
临床试验/NCT07613931
NCT07613931招募中1 期

A Pilot Study to Evaluate and Compare Lymphatic Transport in Patients With Lower Extremity Lymphedema Between Flexitouch Plus® and Flexitouch Plus® With Novel Multi-Chamber Firmware

Tactile Medical1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2026年7月9日最近更新:
干预措施

试验速览

阶段
1 期
状态
招募中
入组人数
5
试验地点
1

研究概览

简要总结

The goal of this pilot study is to learn if a revised method of compression improves lymphatic function compared to the current method of compression. The main questions:

• Does the revised method of compression improve lymph movement and lymphatic propulsion?

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • A diagnosis of active lower extremity lymphedema, as assessed by medical history
  • Participant is a candidate for APCD treatment per the Flexitouch Plus indications for use
  • Must be able to provide informed consent prior to study participation
  • Willing and able to comply with the study protocol requirements and all study-related visit requirements

排除标准

  • Heart failure (acute pulmonary edema, decompensated acute heart failure)
  • Acute venous disease (acute thrombophlebitis, acute deep venous thrombosis, acute pulmonary embolism)
  • Severe peripheral artery disease (critical limb ischemia, including ischemic rest pain, arterial wounds or gangrene)
  • Active skin or limb infection/inflammatory disease (acute cellulitis, other uncontrolled skin or untreated inflammatory skin disease) on the trunk or lower extremities
  • Active cancer or metastasis in the lower extremity lymphatic watersheds
  • Eczema, rash, scarring, or extensive tattoos at imaging sites
  • Participant is pregnant or trying to become pregnant
  • Participants with a history of allergy to iodides, who may be susceptible to iodine present in ICG formulation
  • Patients exhibiting Grade 3 or higher on the CTCAE v6.0 superficial soft tissue fibrosis scale
  • Body Mass Index (BMI) ≥40
  • Participants unable to recline on their backs for up to 60 consecutive minutes and walk in place or tolerate assisted lower extremity movement for 5 minutes

研究组 & 干预措施

Treatment group

Experimental

干预措施: Advanced pneumatic compression device (APCD) (Device)

Treatment group

Experimental

干预措施: Advanced pneumatic compression device (APCD) with revised compression programming (Device)

Treatment group

Experimental

干预措施: Indocyanine Green (IC-Green) (Drug)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluate Advanced Pneumatic Compression Device With... | 临床试验